Chemoinformaics analysis of 8-(3,3-Dimethylallyl)Spatheliachromene
| Molecular Weight | 326.392 | nRot | 2 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 18 |
| Exact Molecular Weight | 326.152 | nRing | 3 |
| Solubility: LogS | -3.098 | nHRing | 2 |
| Solubility: LogP | 5.857 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 51.2774 |
| nHD | 1 | BPOL | 26.4106 |
| QED | 0.826 |
| Synth | 3.26 |
| Natural Product Likeliness | 3.042 |
| NR-PPAR-gamma | 0.875 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.257 |
| Pgp-sub | 0.002 |
| HIA | 0.149 |
| CACO-2 | -4.659 |
| MDCK | 0.0000179 |
| BBB | 0.02 |
| PPB | 0.858562 |
| VDSS | 1.275 |
| FU | 0.0943036 |
| CYP1A2-inh | 0.798 |
| CYP1A2-sub | 0.728 |
| CYP2c19-inh | 0.809 |
| CYP2c19-sub | 0.465 |
| CYP2c9-inh | 0.833 |
| CYP2c9-sub | 0.859 |
| CYP2d6-inh | 0.689 |
| CYP2d6-sub | 0.275 |
| CYP3a4-inh | 0.505 |
| CYP3a4-sub | 0.219 |
| CL | 2.757 |
| T12 | 0.175 |
| hERG | 0.009 |
| Ames | 0.068 |
| ROA | 0.956 |
| SkinSen | 0.527 |
| Carcinogencity | 0.886 |
| EI | 0.026 |
| Respiratory | 0.745 |
| NR-Aromatase | 0.896 |
| Antiviral | Yes |
| Prediction | 0.706872 |